Annual CFO
-$2.85 M
-$609.00 K-27.16%
December 1, 2023
Summary
- As of February 10, 2025, IBO annual cash flow from operations is -$2.85 million, with the most recent change of -$609.00 thousand (-27.16%) on December 1, 2023.
- IBO annual CFO is now -365.24% below its all-time high of -$612.80 thousand, reached on December 1, 2019.
Performance
IBO Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$1.28 M
-$619.00 K-92.94%
September 1, 2024
Summary
- As of February 10, 2025, IBO quarterly cash flow from operations is -$1.28 million, with the most recent change of -$619.00 thousand (-92.94%) on September 1, 2024.
- Over the past year, IBO quarterly CFO has dropped by -$573.00 thousand (-80.48%).
- IBO quarterly CFO is now -284.39% below its all-time high of -$334.30 thousand, reached on June 1, 2021.
Performance
IBO Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$3.10 M
-$614.00 K-24.74%
September 1, 2024
Summary
- As of February 10, 2025, IBO TTM cash flow from operations is -$3.10 million, with the most recent change of -$614.00 thousand (-24.74%) on September 1, 2024.
- Over the past year, IBO TTM CFO has dropped by -$547.00 thousand (-21.46%).
- IBO TTM CFO is now -655.12% below its all-time high of -$410.00 thousand, reached on March 1, 2021.
Performance
IBO TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
IBO Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -27.2% | -80.5% | -21.5% |
| 3 y3 years | - | -160.8% | -150.3% |
| 5 y5 years | -365.2% | -160.8% | -150.3% |
IBO Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -27.2% | at low | -254.0% | at low | -38.1% | at low |
| 5 y | 5-year | -365.2% | at low | -284.4% | at low | -655.1% | at low |
| alltime | all time | -365.2% | at low | -284.4% | at low | -655.1% | at low |
Impact BioMedical Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.28 M(+92.9%) | -$3.10 M(+24.7%) |
| Jun 2024 | - | -$666.00 K(-6.5%) | -$2.48 M(-2.6%) |
| Mar 2024 | - | -$712.00 K(+64.4%) | -$2.55 M(-10.6%) |
| Dec 2023 | -$2.85 M(+27.2%) | -$433.00 K(-35.5%) | -$2.85 M(+2.5%) |
| Sep 2023 | - | -$671.00 K(-8.5%) | -$2.78 M(-4.5%) |
| Jun 2023 | - | -$733.00 K(-27.7%) | -$2.91 M(+6.9%) |
| Mar 2023 | - | -$1.01 M(+179.3%) | -$2.72 M(+21.5%) |
| Dec 2022 | -$2.24 M | -$363.00 K(-54.7%) | -$2.24 M(-22.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$802.00 K(+47.4%) | -$2.88 M(+12.0%) |
| Jun 2022 | - | -$544.00 K(+2.1%) | -$2.57 M(+8.9%) |
| Mar 2022 | - | -$533.00 K(-47.0%) | -$2.37 M(+5.5%) |
| Dec 2021 | -$2.24 M(+265.9%) | -$1.00 M(+104.0%) | -$2.24 M(+81.2%) |
| Sep 2021 | - | -$492.70 K(+47.4%) | -$1.24 M(+66.2%) |
| Jun 2021 | - | -$334.30 K(-18.5%) | -$744.30 K(+81.5%) |
| Mar 2021 | - | -$410.00 K | -$410.00 K |
| Dec 2019 | -$612.80 K | - | - |
FAQ
- What is Impact BioMedical annual cash flow from operations?
- What is the all time high annual CFO for Impact BioMedical?
- What is Impact BioMedical annual CFO year-on-year change?
- What is Impact BioMedical quarterly cash flow from operations?
- What is the all time high quarterly CFO for Impact BioMedical?
- What is Impact BioMedical quarterly CFO year-on-year change?
- What is Impact BioMedical TTM cash flow from operations?
- What is the all time high TTM CFO for Impact BioMedical?
- What is Impact BioMedical TTM CFO year-on-year change?
What is Impact BioMedical annual cash flow from operations?
The current annual CFO of IBO is -$2.85 M
What is the all time high annual CFO for Impact BioMedical?
Impact BioMedical all-time high annual cash flow from operations is -$612.80 K
What is Impact BioMedical annual CFO year-on-year change?
Over the past year, IBO annual cash flow from operations has changed by -$609.00 K (-27.16%)
What is Impact BioMedical quarterly cash flow from operations?
The current quarterly CFO of IBO is -$1.28 M
What is the all time high quarterly CFO for Impact BioMedical?
Impact BioMedical all-time high quarterly cash flow from operations is -$334.30 K
What is Impact BioMedical quarterly CFO year-on-year change?
Over the past year, IBO quarterly cash flow from operations has changed by -$573.00 K (-80.48%)
What is Impact BioMedical TTM cash flow from operations?
The current TTM CFO of IBO is -$3.10 M
What is the all time high TTM CFO for Impact BioMedical?
Impact BioMedical all-time high TTM cash flow from operations is -$410.00 K
What is Impact BioMedical TTM CFO year-on-year change?
Over the past year, IBO TTM cash flow from operations has changed by -$547.00 K (-21.46%)